Introduction
============

Schizophrenia is a severe mental disorder characterized by changes in its higher functions and deterioration of behavior, cognition, emotions, motivation, and perception, and is marked by socio-occupational dysfunction. Schizophrenia manifests with a wide variety of positive (auditory hallucinations and paranoid delusions), negative (affective flattening, anhedonia, and alogia), and cognitive (declined attention and memory) symptoms.[@b1-ndt-12-3129] It is a complex multifactorial psychiatry disorder involving genetic and environmental factors, with a global lifetime prevalence of 0.5%--1%.[@b2-ndt-12-3129]

Family, twin, and adoption studies have shown that genetic factors play a significant role in the pathogenesis of schizophrenia, with the heritability of schizophrenia being estimated at 70%--80%.[@b3-ndt-12-3129],[@b4-ndt-12-3129] Additionally, Lee et al estimated that 23% of variation in liability to schizophrenia is captured by single-nucleotide polymorphisms (SNPs).[@b5-ndt-12-3129] For schizophrenia, some genetic factors were shared with other psychiatric disorders (bipolar disorder, major depressive disorder, autism spectrum disorders, and attention-deficit/hyperactivity disorder),[@b6-ndt-12-3129] and some genetic factors associated with its risk were overlapped with those associated with reproduction traits (eg, age at first birth).[@b7-ndt-12-3129] In short, schizophrenia is highly polygenic.[@b8-ndt-12-3129]

The dopamine hypothesis is one of the main ideas for explaining the etiology of schizophrenia.[@b9-ndt-12-3129] There are several lines of evidence implicating dopamine D2 receptor (DRD2) as the main candidate gene for the risk of schizophrenia.[@b10-ndt-12-3129] In humans, the *DRD2* gene is located on chromosome 11 at q22--q23, extends over 270 kb, and has eight exons.[@b11-ndt-12-3129] Associations between schizophrenia risk and four SNPs have been widely studied: rs1799732 (--141C Ins/Del), rs1801028 (311 Ser/Cys), rs1800497 (TaqIA), and rs6277 (C957T).[@b12-ndt-12-3129],[@b13-ndt-12-3129] The rs1799732 SNP is located in the *DRD2* promoter region and has been demonstrated to affect gene expression in vitro.[@b14-ndt-12-3129] The rs1801028 SNP is the missense variant 960C/G in exon 7 of the *DRD2* gene[@b15-ndt-12-3129] that can alter the physiology and function of the D2 receptor.[@b12-ndt-12-3129] The rs1800497 SNP was previously thought to be located in the *DRD2* 3′-untranslated region and was recently identified as being in exon 8 of the ankyrin repeat and kinase domain containing 1 (ANKK1) gene. This SNP has been considered to alter substrate-binding specificity.[@b16-ndt-12-3129] The rs6277 SNP is located in exon 7 of the *DRD2* gene and alters mRNA folding, leading to a decrease in mRNA stability and translation, and markedly changing dopamine-induced up-regulation of *DRD2* expression.[@b17-ndt-12-3129] In addition, associations between schizophrenia risk and the rs6275 (C939T), rs1079597 (TaqIB), and rs1800498 (TaqID) SNPs have been widely reported.[@b18-ndt-12-3129],[@b19-ndt-12-3129]

While associations between *DRD2* gene polymorphisms and the risk of schizophrenia have been studied extensively, there are still some uncertainties about these associations. The present meta-analysis was therefore performed to further identify the associations between *DRD2* gene polymorphisms and schizophrenia risk. Meta-regression and publication bias, nonparametric trim-and-fill, subgroup, sensitivity, cumulative, and fail-safe number analyses were also performed.

Method
======

Search strategy
---------------

The PubMed, Embase, and China National Knowledge Infrastructure databases were independently searched by two reviewers (He and Wu) to collect the literature related to associations between *DRD2* gene polymorphisms and schizophrenia risk. The last search update was performed in February 2016, and the following keywords were used in the literature search: "schizophrenia", "psychosis", "schizophrenic," "DRD2," "dopamine receptor 2," "dopamine receptor D2", "dopamine D2 receptor", "polymorphism", "variant", "variation", "allele", and "genotype". The species was limited to human. Moreover, the literature references in all of the included documents were searched to find more studies that were consistent with the eligibility criteria.

Eligibility criteria
--------------------

1.  Studies that met the following inclusion criteria were included: Research study with a case--control design.Written in Chinese or English.Investigation of the associations between *DRD2* gene polymorphisms and the risk of schizophrenia.Providing sufficient allele or genotype distribution data of the included cases and controls.

2.  Studies that met any of the following exclusion criteria were excluded: Repetition of information in other literature.A review, comment, or conference proceedings.Results obtained in an animal model.Series of reports or case reports.

Research screening
------------------

The studies were first screened by browsing the titles and abstracts of the identified documents. Secondary screening was then performed by reading the full text of selected reports. Finally, data extraction and quality assessment were performed for the included studies.

Data extraction
---------------

In our present study, two reviewers (He and Wu) independently extracted the following information from the included literature: first author, publication year, mean age of the cases and controls, country, ethnicity, source of controls, numbers of cases and controls, *DRD2* gene locus, diagnostic criteria of schizophrenia, genotyping method, and conformity with Hardy--Weinberg equilibrium (HWE) for the controls. If the allele or genotype distribution data of the cases and controls were not reported in the original articles, the corresponding author was contacted by mail to obtain this information.

Quality assessment
------------------

Two authors (HH and HW) independently performed quality assessment using quality scoring criteria[@b20-ndt-12-3129] based on criteria previously applied in observational studies for addressing genetic epidemiological issues, with the scores ranging from 0 points (worst) to 9 points (best) ([Table S1](#SD1-ndt-12-3129){ref-type="supplementary-material"}). A study was classified as being of low quality when it scored \<6 points. Sensitivity analysis was conducted by deleting these low-quality studies.

Statistical analysis
--------------------

Odds ratios (ORs) and 95% confidence intervals (CIs) were used to evaluate the strengths of the associations between *DRD2* gene polymorphisms and schizophrenia risk. Pooled effect sizes were calculated using the random-effects model. This model evaluated different underlying influences considering both within- and between-study variations, which provided the advantage of accommodating diversity between studies and yielding a more conservative estimate of the assessed effect.[@b21-ndt-12-3129] The present study used an allele comparison model because this maximized the number of included studies.

Cochran's *Q* statistic was used to estimate the degree of heterogeneity in the included studies. Heterogeneity was considered to be high when the *P*-value was \<0.1. The heterogeneity was also quantified using the *I*^2^ statistic and was considered high when *I*^2^\>50%. Based on clinical knowledge, the ethnicity and source of controls were considered to be responsible for heterogeneity, and so these parameters were set as covariates in the meta-regression. A subgroup analysis was also conducted.

Publication bias was analyzed using Begg's funnel plots. An asymmetrical funnel plot indicated the presence of significant publication bias. The symmetry of Begg's funnel plots was judged using Egger's linear regression, and a *P*-value of \<0.05 was considered to indicate that the funnel plots were significantly asymmetrical. The trim-and-fill method was used to correct for publication bias and also to assess the impact of publication bias on the results.

Sensitivity analysis was used to assess both the potential impact of single studies on the pooled effect size and the impact of removing low-quality studies on the obtained results. Cumulative analysis by publication year was used to explore temporal trends in the results. Finally, the fail-safe number of negative studies that would be required to nullify (ie, make *P*\>0.05) the effect size was calculated.

All of the statistical analyses were conducted using Stata software, version 12.0 (Stata Corporation, College Station, TX, USA).

Results
=======

Study characteristics
---------------------

A flow chart of the study selection procedure is shown in [Figure 1](#f1-ndt-12-3129){ref-type="fig"}. Briefly, 1,267 studies were identified after eliminating 304 duplications. After reviewing the abstracts or reading full texts carefully according to eligibility criteria, a further 1,186 studies were excluded. Finally, 81 studies were identified for exploring the associations between *DRD2* gene polymorphisms and susceptibility to schizophrenia in a meta-analysis.

The main features of the included studies are listed in [Table 1](#t1-ndt-12-3129){ref-type="table"}. The 81 studies comprised 45 studies focused on Caucasians, 34 on Asians, and 2 on mixed populations. The distributions of genotypes in the control groups deviated from HWE for the rs1801028, rs1800497, and rs1800498 SNPs in seven studies.[@b11-ndt-12-3129],[@b22-ndt-12-3129]--[@b27-ndt-12-3129] The quality assessment revealed that four studies were of low quality.[@b26-ndt-12-3129],[@b28-ndt-12-3129]--[@b30-ndt-12-3129]

Association between the rs1801028 (311 Ser/Cys) and schizophrenia risk
----------------------------------------------------------------------

A meta-analysis of 42 case--control studies (9,771 cases and 11,900 controls) revealed that the variant allele G (Cys) was associated with increased schizophrenia risk in all populations (*P*=0.009, OR =1.23, 95% CI =1.05--1.44; [Figure 2A](#f2-ndt-12-3129){ref-type="fig"}). The fail-safe number was 104.52, and there was moderate heterogeneity (*I*^2^=35%). Meta-regression indicated that the source of controls may have been responsible for this heterogeneity (*P*\<0.01). The subgroup analysis, whose results are presented in [Table 2](#t2-ndt-12-3129){ref-type="table"}, revealed that the G allele was associated with increased susceptibility to schizophrenia in Asians (*P*=0.04, OR =1.25, 95% CI =1.01--1.55) and hospital-based controls (*P*\<0.01, OR =1.91, 95% CI =1.39--2.61).

Sensitivity analysis indicated that no single study qualitatively changed the pooled ORs ([Figure 3](#f3-ndt-12-3129){ref-type="fig"}). Removing the low-quality studies[@b26-ndt-12-3129],[@b29-ndt-12-3129],[@b30-ndt-12-3129] did not change the results. Four of the studies deviated from HWE,[@b22-ndt-12-3129],[@b24-ndt-12-3129],[@b26-ndt-12-3129],[@b27-ndt-12-3129] but removing them from the analysis did not change the results. Cumulative analysis by publication year confirmed that pooled ORs and 95% CIs were stable and that there was a reliable temporal trend in the results from 1996[@b31-ndt-12-3129] ([Figure 4](#f4-ndt-12-3129){ref-type="fig"}).

In terms of publication bias, Egger's linear regression showed that the funnel plots were asymmetrical (*P*=0.023). The trim-and-fill method suggested that eight studies were missing, and the results for the association between the rs1801028 SNP and schizophrenia changed after replacing the data for these eight studies (OR =1.063, 95% CI =0.892--1.266; [Figure 5](#f5-ndt-12-3129){ref-type="fig"}). This indicates that our analyses were not stable and that future research is very likely to produce different results.

Association between the rs6277 (C957T) and schizophrenia risk
-------------------------------------------------------------

A meta-analysis of 12 case--control studies (2,919 cases and 3,600 controls) revealed that the variant allele T was associated with decreased schizophrenia risk (*P*=0.002, OR =0.80, 95% CI =0.69--0.92; [Figure 2B](#f2-ndt-12-3129){ref-type="fig"}). The fail-safe number was 91.00, there was high heterogeneity (*I* [@b2-ndt-12-3129]=58.5%), and meta-regression indicated that ethnicity may have been responsible for this heterogeneity (*P*\<0.01). A subgroup analysis based on ethnicity showed that the T allele was associated with decreased susceptibility to schizophrenia in Caucasians (*P*\<0.01, OR =0.72, 95% CI =0.66--0.79).

Cumulative analysis by publication year did not show a reliable temporal trend. Sensitivity analysis showed that no single study qualitatively changed the pooled ORs. In terms of publication bias, Egger's linear regression showed that the funnel plots were symmetrical (*P*=0.119).

Association between the rs1799732 (−141C Ins/Del) and schizophrenia risk
------------------------------------------------------------------------

A meta-analysis of 27 case--control studies (6,770 cases and 7,347 controls) demonstrated that the rs1799732 SNP was not associated with schizophrenia risk (*P*=0.26, OR =0.91, 95% CI =0.78--1.07; [Figure 2C](#f2-ndt-12-3129){ref-type="fig"}). There was high heterogeneity (*I*^2^=76%), and meta-regression indicated that neither ethnicity (*P*=0.119) nor the source of controls (*P*=0.452) was responsible for this heterogeneity. A subgroup analysis based on ethnicity showed that the variant type (−141C Del) was associated with decreased susceptibility to schizophrenia in Asians (*P*=0.004, OR =0.76, 95% CI =0.63--0.92). A subgroup analysis based on the source of controls found no significant association between the rs1799732 SNP and schizophrenia risk in population-based controls or hospital-based controls. In terms of publication bias, Egger's linear regression showed that the funnel plots were symmetrical (*P*=0.173).

Association between the rs1800497 (TaqIA) and schizophrenia risk
----------------------------------------------------------------

A meta-analysis of 22 case--control studies (4,017 cases and 4,209 controls) demonstrated that the rs1800497 SNP was not associated with schizophrenia risk (*P*=0.06, OR =0.87, 95% CI =0.75--1.01; [Figure 2D](#f2-ndt-12-3129){ref-type="fig"}). There was high heterogeneity (*I*^2^=72%), and meta-regression indicated that neither ethnicity (*P*=0.612) nor the source of controls (*P*=0.372) was responsible for this heterogeneity. A subgroup analysis based on the source of controls revealed that the variant allele A (A2) was associated with decreased schizophrenia risk in population-based controls (*P*\<0.01, OR =0.84, 95% CI =0.72--0.97). A subgroup analysis based on ethnicity revealed that the rs1800497 SNP was also not associated with susceptibility to schizophrenia. There were four studies of the rs1800497 SNP that included controls that did not conform with HWE, but they did not influence the results.[@b11-ndt-12-3129],[@b23-ndt-12-3129]--[@b25-ndt-12-3129] In terms of publication bias, Egger's linear regression showed that the funnel plots were symmetrical (*P*=0.861).

Association between the other SNPs and schizophrenia risk
---------------------------------------------------------

There was no evidence that the susceptibility to schizophrenia was associated with the rs6275 (T vs C, *P*=0.10, OR =0.92, 95% CI =0.83--1.02), rs1079597 (T vs C, *P*=0.12, OR =0.72, 95% CI =0.47--1.10), or rs1800498 (T vs C, *P*=0.52, OR =1.03, 95% CI =0.93--1.15) SNP. Sensitivity analysis indicated that no single study of the rs1800498 SNP qualitatively changed the pooled ORs. Removing the low-quality study[@b28-ndt-12-3129] did not change the result.

Discussion
==========

A comprehensive analysis about schizophrenia-associated genetic loci had been performed in a genome-wide association study.[@b32-ndt-12-3129] Our meta-analysis results provide evidence that the rs1801028 and rs6277 SNPs are associated with the risk of schizophrenia. A subgroup analysis indicated that the rs1801028 SNP may increase the risk of schizophrenia in Asians and hospital-based controls, the rs6277 SNP may reduce the risk of schizophrenia in Caucasians, the rs1799732 SNP may reduce the risk of schizophrenia in Asians, and the rs1800497 SNP may reduce the risk of schizophrenia in population-based controls.

Yao et al performed a similar study of the associations between *DRD2* gene polymorphisms and schizophrenia risk.[@b12-ndt-12-3129] That study used a genetic model, while our study used an allele contrast model since this made it possible to include the largest number of documents and the maximum sample sizes. Other advantages of the present study were 1) the inclusion of more published documents (including those written in Chinese), which increased the statistical power of our results, 2) more SNPs being investigated, and 3) the application of meta-regression and publication bias, nonparametric trim-and-fill, subgroup, sensitivity, cumulative, and fail-safe number analysis also being performed.

The results of the present study show that the rs1801028 SNP may increase the risk of schizophrenia in Asians and hospital-based controls. Yao et al reported the same result under the dominant model.[@b12-ndt-12-3129] Different results may be obtained for different races due to differences in genetic backgrounds and living conditions.[@b33-ndt-12-3129] Moreover, the results for the subgroup analysis based on hospital-based controls are not reliable because such controls may not be representative and samples of hospital-based controls are often too small, and so these results should be treated cautiously. The results for publication bias were significant, and these changed after being adjusted using the trim-and-fill method, which indicated that those results may not be very stable. This means that if new articles are published in the future, the results of a complete meta-analysis including all available data are very likely to change. The presence of significant publication bias was probably due to our meta-analysis including many small-sample studies. Yao et al found only slight publication bias, but this was not corrected using the trim-and-fill method.[@b12-ndt-12-3129]

Twelve of the included documents related to the rs6277 SNP and the meta-analysis showed that this SNP may reduce the risk of schizophrenia in Caucasians; however, Yao et al did not study this SNP.[@b12-ndt-12-3129] However, our included samples for this SNP were small and the cumulative analysis by publication year did not show a reliable trend. This means that the statistical power of the results may not have been high.

In our meta-analysis the rs1799732 SNP was not associated with schizophrenia risk, and Yao et al obtained the same result under the dominant model.[@b12-ndt-12-3129] After performing subgroup analysis, the current meta-analysis indicated that the rs1799732 SNP might reduce the risk of schizophrenia in Asians. In contrast, Yao et al did not find any correlation between the rs1799732 SNP and schizophrenia risk in different races and different populations. The possible reasons for different conclusions being drawn based on the current and previous meta-analyses of the rs1799732 SNP are 1) more documents being included in the present study, especially the Chinese literature, because this is likely to have greatly increased the sample size for Asians, and 2) the use of different genetic models.

The previous meta-analyses did not explore the correlations between the rs1800497 SNP and schizophrenia risk in all populations. After performing subgroup analysis, the present study found that the rs1800497 SNP was associated with schizophrenia risk in population-based controls. In contrast, Yao et al found that the rs1800497 SNP may increase the risk of schizophrenia in Caucasians.[@b12-ndt-12-3129] The possible reasons for the current and previous meta-analyses drawing different conclusions from their subgroup analyses of the rs1800497 SNP are 1) Yao et al applying the wrong allele or genotype distribution data of cases and controls regarding the study of Nothen et al;[@b34-ndt-12-3129] 2) the smallness of the study sample of Yao et al; 3) that study not including Chinese studies; and 4) our use of different genetic models. These factors mean that the statistical power would have been higher for the present study.

It is important to note the limitations of our meta-analysis. 1) Meaningless or negative results might not be published, which would lead to some degree of publication bias. 2) Schizophrenia is a multifactorial disease, whereas the present study only considered the impact of the *DRD2* gene on schizophrenia risk, and also ignored the possible impacts of environmental factors, age, gender, lifestyle, and diagnosis standards.

In conclusion, this meta-analysis has shown that the rs1801028 SNP may be a risk factor for susceptibility to schizophrenia in Asians, the rs6277 SNP may be a protective factor for susceptibility to schizophrenia in Caucasians, and the rs1799732 SNP may be a protective factor for susceptibility to schizophrenia in Asians. However, the occurrence of schizophrenia represents the cumulative effect of multiple genes, and so only studying a single gene or single polymorphism is unlikely to be adequate. Future studies should pay more attention to the interactions within and between genes as well as within and between their polymorphisms in order to better explain the genetic mechanisms underlying mental illness.

Supplementary material
======================

###### 

Scale for quality assessment

  Criteria                                                                                                                           Score
  ---------------------------------------------------------------------------------------------------------------------------------- -------
  **Representativeness of cases**                                                                                                    
  Consecutive/randomly selected form case population with clearly defined sampling frame                                             2
  Consecutive/randomly selected form case population without clearly defined sampling frame or with extensive                        1
  Not described                                                                                                                      0
  **Definition of the DR**                                                                                                           
  Population- or health-based                                                                                                        2
  Hospital-bases                                                                                                                     1
  Not described                                                                                                                      0
  **Hardy--Weinberg equilibrium in controls**                                                                                        
  Hardy--Weinberg equilibrium                                                                                                        2
  Hardy--Weinberg disequilibrium                                                                                                     1
  **Genotyping examination**                                                                                                         
  Genotyping done under "blinded" condition                                                                                          1
  Unblinded done or not mentioned                                                                                                    0
  **Association assessment**                                                                                                         
  Assess association between genotypes and head and neck cancer with appropriate statistics and adjustment for confounders           2
  Assess association between genotypes and head and neck cancer with appropriate statistics and without adjustment for confounders   1
  Inappropriate statistics used                                                                                                      0
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![Flow diagram of the study selection process.\
**Abbreviations:** CNKI, China National Knowledge Infrastructure; DRD2, dopamine D2 receptor.](ndt-12-3129Fig1){#f1-ndt-12-3129}

###### 

Calculated OR and 95% CI for the associations between *DRD2* gene polymorphism and schizophrenia risk.

**Notes:** (**A**) rs1801028; (**B**) rs6277; (**C**) rs1799732; (**D**) rs1800497. weights are from random effects analysis.

**Abbreviations:** CI, confidence interval; DRD2, dopamine D2 receptor; OR, odds ratio.
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![Sensitivity analysis via deletion of each individual study reflecting the relative influence of each individual dataset on the pooled ORs for the rs1801028.\
**Abbreviations:** CI, confidence interval; OR, odds ratio.](ndt-12-3129Fig3){#f3-ndt-12-3129}

![Cumulative meta-analyses according to publication year for the rs1801028.](ndt-12-3129Fig4){#f4-ndt-12-3129}

![Trim-and-fill plot to correct publication bias for the rs1801028.\
**Abbreviation:** SE, standard error.](ndt-12-3129Fig5){#f5-ndt-12-3129}

###### 

Characteristics of case--control studies on *DRD2* gene polymorphisms and schizophrenia risk included in the meta-analysis

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author                                   Year   Country       Ethnicity              No of sample   Control sources   Mutation analysis method   Criteria            SNP                           HWE (*P*-value)   Quality score   
  ---------------------------------------- ------ ------------- ---------------------- -------------- ----------------- -------------------------- ------------------- ----------------------------- ----------------- --------------- ----
  Caprini et al[@b28-ndt-12-3129]          2011   Scandinavia   Caucasians             837            1,471             PB                         --                  ICD-10 + DSM-III-R + DSM-IV   TaqID             Yes             5

  Dollfus et al[@b35-ndt-12-3129]          1996   France        Caucasians             62             161               PB                         PCR-RFLP            DSM-III-R                     TaqIA             Yes             8

  Luo[@b24-ndt-12-3129]                    2008   China         Asians                 211            201               PB                         Direct sequencing   DSM-IV                        −141C Ins/Del     Yes             6

  Watanabe et al[@b36-ndt-12-3129]         2012   Japan         Asians                 648            664               PB                         TaqMan              DSM-IV                        Ser311Cys         Yes             7

  Crawford et al[@b31-ndt-12-3129]         1996   America       Caucasians             84             81                HB                         Direct sequencing   DSM-III-R                     Ser311Cys         Yes             6

  Dubertret et al[@b13-ndt-12-3129]        2010   France        Caucasians             50             50                PB                         PCR                 DSM-IV                        TaqIB             --              --

  TaqIA                                    Yes    7                                                                                                                                                                                    

  Himei et al[@b37-ndt-12-3129]            2002   Japan         Asians                 190            103               PB                         PCR-RFLP            DSM-IV                        Ser311Cys         Yes             7

  −141C Ins/Del                            Yes    7                                                                                                                                                                                    

  Jonsson et al[@b87-ndt-12-3129]          1996   Sweden        Caucasians             118            78                PB                         PCR                 DSM-III-R                     TaqIA             Yes             7

  Kunii et al[@b62-ndt-12-3129]            2014   Japan         Asians                 12             12                PB                         PCR-RFLP            DSM-IV                        TaqIA             Yes             8

  Srivastava et al[@b4-ndt-12-3129]        2010   India         Caucasians (Indians)   233            224               PB                         PCR-RFLP            DSM-IV                        −141C Ins/Del     Yes             8

  TaqIA                                    Yes    8                                                                                                                                                                                    

  TaqIB                                    --     --                                                                                                                                                                                   

  Ser311Cys                                Yes    8                                                                                                                                                                                    

  Arinami et al[@b47-ndt-12-3129]          1996   Japan         Asians                 136            279               PB                         PCR                 ICD-10 + DSM-III-R            Ser311Cys         Yes             7

  Arinami et al[@b57-ndt-12-3129]          1997   Japan         Asians                 260            312               PB                         PCR-RFLP            DSM-III-R                     −141C Ins/Del     Yes             7

  Aslan et al[@b23-ndt-12-3129]            2010   Turkey        Caucasians             99             109               PB                         PCR                 DSM-IV                        TaqIA             No              6

  Behravan et al[@b11-ndt-12-3129]         2008   Iran          Caucasians             38             63                PB                         PCR                 DSM-IV                        TaqIB             Yes             7

  TaqIA                                    No     6                                                                                                                                                                                    

  Betcheva et al[@b1-ndt-12-3129]          2009   Bulgaria      Caucasians             255            556               PB                         PCR                 DSM-IV                        C957T             Yes             8

  C939T                                    Yes    8                                                                                                                                                                                    

  Breen et al[@b63-ndt-12-3129]            1999   England       Caucasians             439            437               PB                         PCR                 DSM-III-R + DSM-IV            −141C Ins/Del     Yes             7

  Chen et al[@b38-ndt-12-3129]             1996   China         Asians                 114            88                PB                         PCR                 DSM-III-R                     Ser311Cys         Yes             6

  Cordeiro et al[@b14-ndt-12-3129]         2009   Brazil        Mixed                  229            733               PB                         --                  DSM-IV                        −141C Ins/Del     Yes             8

  Cordeiro and Vallada[@b16-ndt-12-3129]   2014   Brazil        Mixed                  235            834               PB                         PCR                 DSM-IV                        TaqIA             Yes             8

  Dubertret et al[@b15-ndt-12-3129]        2004   France        Caucasians             103            83                PB                         PCR-RFLP            DSM-IV                        −141C Ins/Del     Yes             7

  TaqIB                                    --     --                                                                                                                                                                                   

  TaqID                                    --     --                                                                                                                                                                                   

  Ser311Cys                                Yes    7                                                                                                                                                                                    

  TaqIA                                    Yes    7                                                                                                                                                                                    

  Dubertret et al[@b13-ndt-12-3129]        2010   France        Caucasians             144            142               PB                         TaqMan              DSM-IV                        TaqIA             Yes             8

  C957T                                    --     --                                                                                                                                                                                   

  Ser311Cys                                Yes    8                                                                                                                                                                                    

  −141C Ins/Del                            Yes    8                                                                                                                                                                                    

  TaqID                                    --     --                                                                                                                                                                                   

  TaqIB                                    --     --                                                                                                                                                                                   

  Fan et al[@b39-ndt-12-3129]              2010   China         Asians                 421            404               PB                         PCR                 DSM-IV                        Ser311Cys         Yes             7

  C957T                                    Yes    7                                                                                                                                                                                    

  C939T                                    Yes    7                                                                                                                                                                                    

  Golimbet et al[@b40-ndt-12-3129]         2011   Russia        Caucasians             366            387               PB                         PCR                 ICD-10                        Ser311Cys         Yes             8

  Gupta et al[@b41-ndt-12-3129]            2009   India         Caucasians (Indians)   254            225               PB                         PCR                 DSM-IV                        −141C Ins/Del     Yes             8

  Ser311Cys                                Yes    8                                                                                                                                                                                    

  C957T                                    Yes    8                                                                                                                                                                                    

  C939T                                    Yes    8                                                                                                                                                                                    

  Hanninen et al[@b64-ndt-12-3129]         2006   Finland       Caucasians             188            384               PB                         PCR                 DSM-IV                        C957T             Yes             8

  Harano[@b42-ndt-12-3129]                 1997   Japan         Asians                 70             101               HB                         PCR                 DSM-III-R                     Ser311Cys         Yes             6

  Hoenicka et al[@b65-ndt-12-3129]         2006   Spain         Caucasians             131            364               PB                         PCR                 DSM-IV                        C957T             Yes             7

  Hori et al[@b43-ndt-12-3129]             2001   Japan         Asians                 241            201               PB                         PCR                 DSM-IV                        Ser311Cys         Yes             7

  −141C Ins/Del                            Yes    7                                                                                                                                                                                    

  Iwata et al[@b44-ndt-12-3129]            2003   Japan         Asians                 51             63                PB                         PCR-RFLP            DSM-IV                        Ser311Cys         Yes             7

  Jonsson et al[@b66-ndt-12-3129]          1999   Sweden        Caucasians             129            179               HB                         PCR                 DSM-III-R                     −141C Ins/Del     Yes             6

  Jonsson et al[@b45-ndt-12-3129]          2003   Sweden        Caucasians             173            236               HB                         PCR                 DSM-III-R                     Ser311Cys         Yes             6

  Kaneshima et al[@b46-ndt-12-3129]        1997   Japan         Asians                 78             112               PB                         PCR                 RDC + DSM-IV                  Ser311Cys         Yes             7

  Kukreti et al[@b2-ndt-12-3129]           2006   India         Caucasians (Indians)   101            145               PB                         PCR                 DSM-IV                        C957T             Yes             8

  C939T                                    Yes    8                                                                                                                                                                                    

  Kurt et al[@b67-ndt-12-3129]             2011   Turkey        Caucasians             73             60                PB                         PCR-RFLP            DSM-IV                        −141C Ins/Del     Yes             7

  Lafuente et al[@b68-ndt-12-3129]         2008   Spain         Caucasians             243            291               HB                         PCR                 DSM-IV                        TaqIB             Yes             7

  TaqIA                                    Yes    7                                                                                                                                                                                    

  −141C Ins/Del                            Yes    7                                                                                                                                                                                    

  Laurent et al[@b48-ndt-12-3129]          1994   France        Caucasians             113            184               PB                         --                  DSM-III-R                     Ser311Cys         Yes             6

  Lawford et al[@b10-ndt-12-3129]          2005   Australia     Caucasians             154            148               PB                         PCR                 DSM-IV                        C957T             Yes             7

  Li et al[@b70-ndt-12-3129]               1998   England       Caucasians             151            145               HB                         PCR                 DSM-IV + DSM-III-R            −141C Ins/Del     Yes             6

  Monakhov et al[@b69-ndt-12-3129]         2008   Russia        Caucasians             311            364               PB                         PCR                 DSM-IV                        C957T             Yes             7

  C939T                                    Yes    7                                                                                                                                                                                    

  TaqIA                                    Yes    7                                                                                                                                                                                    

  Ohara et al[@b3-ndt-12-3129]             1996   Japan         Asians                 153            121               PB                         PCR                 DSM-IV                        Ser311Cys         Yes             7

  Ohara et al[@b71-ndt-12-3129]            1998   Japan         Asians                 170            121               PB                         PCR                 DSM-IV                        −141C Ins/Del     Yes             8

  Parsons et al[@b25-ndt-12-3129]          2007   Spain         Caucasians             119            165               PB                         PCR-RFLP            DSM-IV                        −141C Ins/Del     Yes             7

  TaqIA                                    No     6                                                                                                                                                                                    

  Saiz et al[@b72-ndt-12-3129]             2010   Spain         Caucasians             288            421               PB                         PCR-RFLP            DSM-IV                        −141C Ins/Del     Yes             9

  Sanders et al[@b49-ndt-12-3129]          2008   Europe        Caucasians             1,870          2,002             PB                         TaqMan              DSM-IV                        Ser311Cys         Yes             8

  −141C Ins/Del                            Yes    8                                                                                                                                                                                    

  Sasaki et al[@b26-ndt-12-3129]           1996   Europe        Caucasians             273            255               HB                         PCR                 DSM-III-R                     Ser311Cys         Yes             5

  Spurlock et al[@b50-ndt-12-3129]         1998   Europe        Caucasians             373            413               PB                         PCR                 DSM-III-R                     Ser311Cys         Yes             7

  Stöber et al[@b73-ndt-12-3129]           1998   German        Caucasians             260            290               PB                         PCR                 ICD-10                        −141C Ins/Del     Yes             7

  Tallerico et al[@b74-ndt-12-3129]        1999   America       Caucasians             50             51                PB                         PCR                 DSM-III-R                     −141C Ins/Del     Yes             7

  Tanaka et al[@b51-ndt-12-3129]           1996   Japan         Asians                 106            106               PB                         PCR                 DSM-III-R                     Ser311Cys         Yes             7

  Tsutsumi et al[@b22-ndt-12-3129]         2011   Japan         Asians                 407            384               PB                         PCR-RFLP            DSM-IV                        C957T             Yes             7

  Ser311Cys                                No     6                                                                                                                                                                                    

  Verga et al[@b52-ndt-12-3129]            1997   Italy         Caucasians             103            97                PB                         PCR                 DSM-III-R                     Ser311Cys         Yes             7

  Fujiwara et al[@b54-ndt-12-3129]         1997   Japan         Asians                 52             26                PB                         PCR                 DSM-IV + ICD-10               Ser311Cys         Yes             7

  Kampman et al[@b75-ndt-12-3129]          2003   Finland       Caucasians             93             94                PB                         PCR                 DSM-IV                        −141C Ins/Del     Yes             7

  Morimoto et al[@b55-ndt-12-3129]         2002   Japan         Asians                 48             48                PB                         PCR                 DSM-IV + ICD-10               Ser311Cys         Yes             7

  Vijayan et al[@b19-ndt-12-3129]          2007   India         Caucasians (Indians)   213            196               PB                         PCR                 DSM-IV                        TaqIB             Yes             8

  TaqIA                                    Yes    8                                                                                                                                                                                    

  TaqID                                    Yes    8                                                                                                                                                                                    

  C939T                                    Yes    8                                                                                                                                                                                    

  Ser311Cys                                Yes    8                                                                                                                                                                                    

  Xiao et al[@b76-ndt-12-3129]             2013   China         Asians                 120            100               PB                         PCR                 DSM-IV-TR                     −141C Ins/Del     Yes             7

  Comings et al[@b77-ndt-12-3129]          1991   America       Caucasians             87             69                HB                         PCR                 DSM-III-R                     TaqIA             Yes             7

  Sanders et al[@b78-ndt-12-3129]          1993   America       Caucasians             55             51                PB                         PCR-RFLP            DSM-III-R + RDC               TaqIA             Yes             8

  Campion et al[@b79-ndt-12-3129]          1994   France        Caucasians             80             80                PB                         PCR-RFLP            DSM-III-R                     TaqIA             Yes             7

  Itokawa et al[@b58-ndt-12-3129]          1993   Japan         Asians                 50             110               PB                         PCR-RFLP\           DSM-III-R                     Ser311Cys         Yes             7
                                                                                                                                                   SSCP analysis                                                                       

  Nothen et al[@b34-ndt-12-3129]           1993   German        Caucasians             60             60                PB                         PCR                 DSM-III-R                     TaqIA             Yes             7

  Arinami et al[@b9-ndt-12-3129]           1994   Japan         Asians                 156            300               HB                         PCR                 DSM-III-R                     Ser311Cys         Yes             6

  Asherson et al[@b59-ndt-12-3129]         1994   England       Caucasians             112            64                PB                         PCR                 DSM-III-R                     Ser311Cys         Yes             6

  Gejman et al[@b61-ndt-12-3129]           1994   America       Caucasians             106            113               HB                         PCR-RFLP            DSM-III-R                     Ser311Cys         Yes             7

  Hattori et al[@b27-ndt-12-3129]          1994   Japan         Asian                  100            100               PB                         PCR-RFLP            DSM-III-R                     Ser311Cys         No              6

  Nanko et al[@b60-ndt-12-3129]            1994   Japan         Asian                  100            100               PB                         PCR                 DSM-III-R                     Ser311Cys         Yes             6

  Nothen et al[@b34-ndt-12-3129]           1993   German        Caucasians             179            138               PB                         PCR                 DSM-III-R                     Ser311Cys         Yes             7

  Shaikh et al[@b29-ndt-12-3129]           1994   England       Caucasians             147            100               HB                         PCR                 DSM-III-R                     Ser311Cys         No              5

  Sobell et al[@b30-ndt-12-3129]           1994   America       Caucasians             338            1,914             HB                         --                  --                            Ser311Cys         Yes             5

  Inada et al[@b80-ndt-12-3129]            1999   Japan         Asian                  234            94                PB                         PCR                 ICD-10                        −141C Ins/Del     Yes             8

  Serretti et al[@b81-ndt-12-3129]         2000   Italy         Caucasians             366            267               HB                         --                  --                            Ser311Cys         Yes             --

  Itokawa et al[@b53-ndt-12-3129]          2010   Japan         Asian                  156            300               HB                         SSCP                DSM-III-R                     Ser311Cys         Yes             7

  291                                      579                  PCR                                                                                                                                                                    

  Li[@b82-ndt-12-3129]                     2014   China         Asian                  915            421               PB                         PCR-AFLP\           ICD-10 + CCMD-II-R            TaqIA             Yes             7
                                                                                                                                                   Sequenom\                                                                           
                                                                                                                                                   MassARRAY                                                                           

  Fan et al[@b56-ndt-12-3129]              1996   China         Asian                  105            108               PB                         PCR                 ICD-10                        Ser311Cys         Yes             7

  Liu et al[@b33-ndt-12-3129]              2012   China         Asian                  317            310               PB                         PCR                 DSM-IV                        TaqIA             Yes             7

  Liu et al[@b83-ndt-12-3129]              2009   China         Asian                  128            124               PB                         PCR-RFLP            CCMD-3                        −141C Ins/Del     Yes             7

  Luo[@b24-ndt-12-3129]                    2008   China         Asian                  512            480               PB                         PCR                 DSM-IV                        −141C Ins/Del     Yes             7

  Ser311Cys                                No     6                                                                                                                                                                                    

  C957T                                    Yes    7                                                                                                                                                                                    

  C939T                                    Yes    7                                                                                                                                                                                    

  TaqIA                                    No     6                                                                                                                                                                                    

  Shen et al[@b84-ndt-12-3129]             2011   China         Asian                  120            100               PB                         PCR                 DSM-IV                        −141C Ins/Del     Yes             7

  Zhang et al[@b85-ndt-12-3129]            2003   China         Asian                  67             77                PB                         PCR                 CCMD-II-R                     TaqIA             Yes             6

  Zheng[@b18-ndt-12-3129]                  2012   China         Asian                  92             96                PB                         PCR                 --                            C957T             Yes             6

  C939T                                    Yes    6                                                                                                                                                                                    

  Ser311Cys                                Yes    6                                                                                                                                                                                    

  Liang[@b86-ndt-12-3129]                  2005   China         Asian                  101            105               PB                         PCR                 DSM-IV + CCMD-3               −141C Ins/Del     Yes             7
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Abbreviations:** AFLP, amplified fragment length polymorphism; CC, complication or comorbidity; CCMD, Chinese Classification of Mental Disorders; DSM, The Diagnostic and Statistical Manual of Mental Disorder; HB, hospital-based; PB, population-based; HWE, Hardy--Weinberg equilibrium; ICD-10, International Statistical Classification of Diseases and Related Health Problems -- 10th version; PCR, polymerase chain reaction; RDC, Research Diagnostic Criteria; SNP, single-nucleotide polymorphisms; RFLP, restriction fragment length polymorphism.

###### 

Subgroup analysis of case--control studies on *DRD2* gene polymorphisms and schizophrenia risk

  SNP              Subgroup type     Subgroup           N      *P*-value    OR           95% CI       *I*^2^ (%)
  ---------------- ----------------- ------------------ ------ ------------ ------------ ------------ ------------
  rs1801028        Control sources   Population-based   31     0.99         1.00         0.88, 1.14   0
  Hospital-based   11                \<0.01             1.91   1.39, 2.61   31                        
  Ethnicity        Caucasians        19                 0.09   1.22         0.97, 1.54   41           
  Asians           23                0.04               1.25   1.01, 1.55   31                        
  rs6277           Ethnicity         Caucasians         8      \<0.01       0.72         0.66, 0.79   0
  Asians           4                 0.37               1.17   0.83, 1.64   46                        
  rs1799732        Control sources   Population-based   24     0.36         0.92         0.78, 1.10   77
  Hospital-based   3                 0.46               0.81   0.47, 1.41   71                        
  Ethnicity        Caucasians        15                 0.33   1.11         0.90, 1.36   71           
  Asians           11                0.004              0.76   0.63, 0.92   56                        
  Mixed            1                 0.002              0.61   0.44, 0.83   --                        
  rs1800497        Control sources   Population-based   20     0.02         0.84         0.72, 0.97   71
  Hospital-based   2                 0.46               1.50   0.51, 4.47   86                        
  Ethnicity        Caucasians        16                 0.24   0.88         0.72, 1.08   71           
  Asians           5                 0.29               0.85   0.63, 1.15   82                        
  Mixed            1                 0.06               0.82   0.66, 1.01   --                        

**Abbreviations:** CI, confidence intervals; DRD2, dopamine D2 receptor; OR, odds ratios; SNP, single-nucleotide polymorphisms.
